ErVimmune at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

ErVimmune takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth SU25. ErVimmune brings cancer vaccines and T cell therapies aimed at tumors that draw little immune attack, built on tumor antigens that many patients share.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
ErVimmune
Lyon, France
ervimmune.com
BiotechStart-up Plus
Develops cancer vaccines and T cell therapies against shared, non-mutated tumor antigens from endogenous retroviruses, aimed at cold tumors.
Booth
Exhibiting at Booth SU25
Talk
Tue Oct 20
13:05
Start-up Pitch 6: ErVimmune: Unlocking a New Class of Tumor Antigens to Treat Cold Tumors
Startup Pitches
Cancer & therapeutic vaccines

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ErVimmune

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction